Skip to content
TrialScanner

NCT06378047

Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

Phase 1CompletedANGOCollaborator

Registry record

Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Conditions
Pancreatic Cancer; Locally Advanced Pancreatic Cancer
Primary completion
Sep 15, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06378047 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06378047: Irreversible Electroporation... | TrialScanner